Not all stem cells are created equal part 3

Stem cell 1


One solution is to use allogeneic cells from a therapeutically potent donor, but even optimal cells may not provide benefit if the recipient’s regenerative capacity is poor. It was suggested that although the focus in stem cells trials is typically on the administered  cells, there is little on the patient and tissue targeted for regeneration. Indeed, there is evidence that the variable cell potency observed across patients in clinical trials reflects not just the quality of delivered cells but also the underlying regenerative capacity of the treated patient. With the growing understanding that stem cell therapy functions to a large extent via paracrine  mechanisms, it seems clear that the recipient’s regenerative capacity is likely a critical determinant of therapeutic effect.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s